Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

AXL expression + EGFR mutation

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

EGFR expression (46)

EGFR overexpression (34)

AXL expression (10)

AXL overexpression (10)

EGFR positive (8)

EGFR negative (6)

EGFR negative + ALK negative (4)

EGFR expression + ALK positive (3)

EGFRVIII expression + PTEN expression (3)

EGFRvIII expression (3)

EGFR expression + MET expression (2)

EGFR overexpression + HER-2 overexpression (2)

MMP17 expression + EGFR expression + RB1 expression (2)

MUC1 expression + EGFR expression (2)

TROP2 expression + EGFR expression (2)

EGFR expression + HER-2 expression (1)

EGFR underexpression (1)

EGFRVIII overexpression (1)

EPHA2 overexpression + EGFR overexpression (1)

GPC3 positive + EGFR expression (1)

AXL overexpression + PD-L1 expression (1)

AXL positive (1)

AXL underexpression (1)

OPCML underexpression + AXL overexpression (1)

DRD2 expression + EGFR overexpression (0)

YAP1 overexpression + EGFR overexpression (0)

EGFR expression (46)

EGFR overexpression (34)

AXL expression (10)

AXL overexpression (10)

EGFR positive (8)

EGFR negative (6)

EGFR negative + ALK negative (4)

EGFR expression + ALK positive (3)

EGFRVIII expression + PTEN expression (3)

EGFRvIII expression (3)

EGFR expression + MET expression (2)

EGFR overexpression + HER-2 overexpression (2)

MMP17 expression + EGFR expression + RB1 expression (2)

MUC1 expression + EGFR expression (2)

TROP2 expression + EGFR expression (2)

EGFR expression + HER-2 expression (1)

EGFR underexpression (1)

EGFRVIII overexpression (1)

EPHA2 overexpression + EGFR overexpression (1)

GPC3 positive + EGFR expression (1)

AXL overexpression + PD-L1 expression (1)

AXL positive (1)

AXL underexpression (1)

OPCML underexpression + AXL overexpression (1)

DRD2 expression + EGFR overexpression (0)

YAP1 overexpression + EGFR overexpression (0)

›

AXL expression + EGFR mutation	Non Small Cell Lung Cancer	AXL expression + EGFR mutation	Non Small Cell Lung Cancer	osimertinib Sensitive: C3 – Early Trials osimertinib Sensitive : C3	osimertinib Sensitive: C3 – Early Trials osimertinib Sensitive : C3
AXL expression + EGFR mutation	Non Small Cell Lung Cancer	AXL expression + EGFR mutation	Non Small Cell Lung Cancer	erlotinib + ramucirumab Resistant: D – Preclinical erlotinib + ramucirumab Resistant : D	erlotinib + ramucirumab Resistant: D – Preclinical erlotinib + ramucirumab Resistant : D